The development of monoclonal human rabies virus-neutralizing antibodies as a substitute for pooled human immune globulin in the prophylactic treatment of rabies virus exposure

Journal of Immunological Methods

Volumn 235, Issue 1-2, 2000, Pages 81-90

  Champion, J M ^a   Kean, R B ^a   Rupprecht, C E ^b   Notkins, A L ^c   Koprowski, H ^a   Dietzschold, B ^a   Hooper, D C ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Human monoclonal antibodies; Passive immunization; Rabies post exposure prophylaxis; Rabies virus

Indexed keywords

MONOCLONAL ANTIBODY; RABIES IMMUNOGLOBULIN; RABIES VACCINE;

ANIMAL CELL; ARTICLE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MOUSE; MYELOMA CELL; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RABIES; RABIES VIRUS; VIRUS INFECTION; VIRUS NEUTRALIZATION;

ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; HUMANS; IMMUNIZATION, PASSIVE; NEUTRALIZATION TESTS; RABIES; RABIES VIRUS;

ANIMALIA; RABIES VIRUS;

EID: 0033962738     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-1759(99)00223-9     Document Type: Article

References (29)

1. Cox J.H., Dietzschold B., Schneider L.G. Rabies virus glycoprotein: II. Biological and serological characterization. Infect. Immun. 16:1977;754.
2. Dietzschold B. Monoclonal antibodies in rabies therapy. Clin. Immunother. 1:1994;245.
3. Dietzschold, B., 1996. Techniques for the purification of rabies virus, its subunits and recombinants products. In: Meslin, F.-X., Kaplan, M.M., Koprowski, H. (Eds.), Laboratory Techniques in Rabies. World Health Organization, Geneva, p. 175.
4. Dietzschold B., Wiktor T.J., Wunner W.H., Varrichio A. Chemical and Immunological analysis of the rabies soluble glycoprotein. Virology. 124:1983;330.
5. Dietzschold B., Tollis M., Rupprecht C.E., Celis E., Koprowski H. Antigenic variation in rabies and rabies related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody. J. Infect. Dis. 156:1987;815.
6. Dietzschold B., Gore M., Casali P., Ueki Y., Rupprecht C.E., Notkins A.L., Koprowski H. Biological characterization of human monoclonal antibodies to rabies virus. J. Virol. 65(6):1990;3087.
7. Dietzschold B., Kao M., Zheng Y.M., Chen Z.Y., Maul G., Fu Z.F., Rupprecht C.E., Koprowski H. Delineation of putative mechanisms involved in the antibody-mediated clearance of rabies virus from the central nervous system. Proc. Natl. Acad. Sci. U.S.A. 89:1992;7252.
8. Dorfman N., Dietzschold B., Kajiyama W., Fu Z.F., Koprowski H., Notkins A.L. Development of human monoclonal antibodies to rabies. Hybridoma. 13:1994;397.
9. Enssle K., Kurrle R., Kohler R., Muller H., Kanzy E.J., Hilfenhaus J., Seiler F.R. A rabies-specific human monoclonal antibody that protects mice against lethal rabies. Hybridoma. 10:1991;547.
10. Hattwick M.A.W., Corey L., Creech W.B. Clinical use of human globulin immune to rabies virus. J. Infect. Dis. 133(suppl.):1976;A266.
11. Henderson E., Miller G., Robinson J., Heston L. Efficiency of transformation of lymphocytes by Epstein-Barr virus. J. Exp. Med. 76:1977;152.
12. Hooper, D.C., 1997. Rabies Virus. In: N.R. Rose (Ed.), Manual of Clinical Laboratory Immunology, 5th edn., Part II, Immunologic Diagnosis and Monitoring of Disease, ASM Press, WA, p. 755.
13. Hooper D.C., Morimoto K., Bette M., Weihe M., Koprowski H., Dietzschold B. Collaboration of antibody and inflammation in the clearance of rabies virus from the CNS. J. Virology. 72:1998;3711.
14. Lafon M., Wiktor T.J., Macfarlan R.I. Antigenic sites on the CVS rabies virus glycoprotein: analysis with monoclonal antibodies. J. Gen. Virol. 64:1983;843.
15. Lodmell D.L., Esposito J.J., Ewalt L.C. Rabies virus antinucleoprotein antibody protects against rabies virus challenge and inhibits rabies virus replication in vitro. J. Virol. 67:1993;6080.
16. Morimoto K., Patel M., Corisdeo S., Hooper D.C., Fu Z.F., Rupprecht C.E., Koprowski H., Dietzschold B. Characterization of a unique variant of rabies virus carried by silver-haired bats which is responsible for a newly emerging form of human rabies in North America. Proc. Natl. Acad. Sci. USA. 93:1996;5653.
17. Nevens J.R., Mallia A.K., Wendt M.W., Smith P.K. Affinity chromatographic purification of immunoglobulin M antibodies utilizing immobilized mannan binding protein. J. Chromatogr. 597:1992;247.
18. Plebanski M., Saunders M., Burtles S.S., Crowe S., Hooper D.C. Primary and secondary human in vitro T-cell responses to soluble antigens are mediated by subsets bearing different CD45 isoforms. Immunology. 75:1992;86.
19. Rando, R.F., Notkins, A.L., 1994. Production of human monoclonal antibodies against rabies virus. In: Rupprecht, C.E., Dietzschold, B., Koprowski, H. (Eds.), Lyssaviruses, CTMI 187, Springer-Verlag, p. 195.
20. Schumacher C.L., Dietzschold B., Ertl H.C.J., Niu H.S., Rupprecht C.E., Koprowski H. Use of mouse anti rabies monoclonal antibodies in postexposure treatment of rabies. J. Clin. Invest. 84:1989;971.
21. Schumacher C.L., Ertl H.C.J., Koprowski H., Dietzschold B. Inhibition of immune responses against rabies virus by monoclonal antibodies directed against rabies virus antigens. Vaccine. 10:1992;754.
22. Swaminathan S., Huneycutt B., Reiss C., Kieff E. Epstein-Barr Virus small RNAs (EBERs) do not modulate interferon in infected B cells. J. Virol. 66:1992;5133.
23. Teng N.N., Lam K.S., Calvo Riera F., Kaplan H.S. Construction and testing of mouse-human heteromyelomas for human monoclonal antibody production. Proc. Natl. Acad. Sci. USA. 80:1983;7308.
24. Ueki Y., Goldfarb I.S., Harindranath N., Gore M., Koprowski H., Notkins A.L., Casali P. Clonal analysis of a human antibody response: Quantitation of precursors of antibody-producing cells and generation and characterization of monclonal IgM, IgG, and IgA to rabies virus. J. Exp. Med. 171:1990;19.
25. Waldman, T.A., Strober, W., Blaese, R.M., 1970. In: Merler, E. (Ed.), Immunoglobulins, National Academy of Science, Washington, DC, p. 33.
26. Wiktor T.J., Macfarlan R.I., Foggin C.M., Koprowski H. Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies. Dev. Biol. Stand. 57:1984;199.
27. Wilde H., Choomkasien P., Hemachudha T., Supich C., Chutivongse S. Failure of rabies postexposure treatment in Thailand. Vaccine. 7:1989;478.
28. Wilde H., Sirikawin S., Sabcharoen A., Kingnate D., Tantawichien T., Harischandra P.A., Chaiyabutr N., de Silva D.G., Fernando L., Liyanage J.B., Sitprija V. Failure of postexposure treatment of rabies in children. Clin. Infect. Dis. 22:1996;228.
29. World Health Organization, 1997. WHO recommendations on rabies post-exposure treatment and the correct technique of intradermal immunization against Rabies. WHO/EMC/ZOO.96.6. World Health Organization, Division of Emerging and other Communicable Diseases Surveillance and Control, Geneva.